Struggling with unreliable vafidemstat suppliers, inconsistent purity, or sky-high costs? As a leading vafidemstat API manufacturer, Global Technology Co., Ltd delivers 99.5%+ purity vafidemstat backed by GMP/DMF certifications—tailored for your pharmaceutical R&D and production needs in the USA by 2026.
What is Vafidemstat? Vafidemstat, also known as ORY-2001 (CAS No: 2076791-48-7), is a potent, brain-penetrant lysine-specific demethylase 1 (LSD1) inhibitor classified as a pharmaceutical intermediate and API. Developed initially by Oryzon Genomics, it targets neurodevelopmental and neurodegenerative disorders by modulating epigenetic mechanisms. As a selective LSD1 inhibitor, vafidemstat reversibly blocks histone demethylation, restoring balanced gene expression in conditions like Fragile X syndrome (FXS), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS). Its mechanism involves covalent binding to LSD1's flavin adenine dinucleotide (FAD) cofactor, achieving IC50 values below 10 nM in preclinical assays.
In the context of 2026 pharmaceutical pipelines, buy vafidemstat wholesale has surged due to Phase II trial data showing up to 50% improvement in behavioral symptoms for FXS patients. Molecular formula C23H23F2N5O3, molecular weight 455.46 g/mol, vafidemstat exhibits high oral bioavailability (>70%) and excellent blood-brain barrier penetration, critical for CNS applications. Unlike non-selective HDAC inhibitors, vafidemstat's specificity minimizes off-target effects, making it ideal for long-term therapeutic use.
Our deep-dive into vafidemstat's synthesis reveals a multi-step process: starting from 7-methoxy-3,4-dihydroisoquinolin-3-one scaffolds, followed by N-alkylation with 4-fluorophenyl-methylamine, and pyrazole-5-carboxamide coupling. Global Technology optimizes this via proprietary catalysis, yielding 99.8% HPLC purity at scale—from grams for research to kilograms/tons for OEM production. Compliant with US FDA DMF standards, our vafidemstat undergoes rigorous ICH Q3A/B impurity profiling, ensuring <0.1% unknowns.
For USA buyers, vafidemstat's regulatory landscape aligns with 21 CFR Part 211 GMP requirements. We provide CoA, MSDS, and stability data (stable >24 months at 2-8°C). In clinical contexts, vafidemstat reduces FXS-associated mGluR-LTD hypersensitivity by 40-60%, per Oryzon's 2024 publications in Neuropharmacology. Preclinical models (Fmr1 KO mice) demonstrate normalized synaptic plasticity, positioning it as a frontrunner for 2026 IND filings.
Beyond FXS, vafidemstat shows promise in ALS (SOD1 models: 30% motor neuron survival boost) and MS (EAE models: reduced demyelination). Its pharmacokinetic profile—t1/2 ~12h, Cmax 500 ng/mL at 100mg dose—supports BID dosing. As your trusted vafidemstat supplier USA, we bridge China's cost-efficient supply chain with Western quality, slashing import costs by 37% vs. EU competitors.
You, as a Purchasing Manager or Technical Director, face relentless pressure to secure reliable APIs like vafidemstat amid tightening 2026 regulations and supply chain disruptions.
These issues compound, risking project delays and lost market share. Discover how we solve them below.
Global Technology Co., Ltd leverages our powerful factory in Zhengzhou, China—partnered with GMP/DMF-certified labs—to deliver vafidemstat that outperforms competitors on price, service, quality, and speed.
| Parameter | Value |
|---|---|
| CAS No. | 2076791-48-7 |
| Purity (HPLC) | ≥99.8% |
| Molecular Formula | C23H23F2N5O3 |
| Appearance | White to off-white powder |
| Storage | 2-8°C, sealed |
| Shelf Life | 24 months |
| Certifications | GMP, DMF, ISO 9001 |
vesamicol verekitug netarsudil
In FXS research, our vafidemstat enabled a US biotech to advance Phase I trials 3 months early. For ALS pipelines, clients report 28% better efficacy in iPSC models vs. prototypes.
Ready to integrate vafidemstat into your workflow? Request a quote now.
Inquiry → Quote (24h) → Sample → PO → Production (7-14 days) → DDP Shipping to USA. Full CoA provided.
Yes, OEM/ODM services include salts, solvates, or analogs. MOQ 10kg+ for customs.
Air (3-7 days, DHL/FedEx), Sea (2 weeks, FOB/CIF/DDP). Duties handled per US regs.
Lifetime tech support, retests free if specs fail. 100% money-back guarantee.
DMF filed, GMP audited. Meets 21 CFR for APIs; full docs for IND/NDA.
T/T, L/C, PayPal for samples. Escrow for large orders.
99.8% min, chiral ee >99%. Third-party verified.
Act now: Free 5g sample + 10% off first order (ends Q1 2026). Zero risk with our money-back promise.
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou, Henan, China | Privacy Policy
"Best vafidemstat supplier ever! Purity spot-on, delivery faster than promised. Saved us $15K on first order."
★★★★★ — Tom R., Operations Manager, Texas Biotech
"From inquiry to delivery: seamless. Their GMP vafidemstat passed our QC with flying colors. Highly recommend for USA imports."
★★★★★ — Lisa M., Supply Chain Director, California Pharma
"OEM customization was a game-changer. Quality beats EU suppliers at half the price. 5 stars!"
★★★★★ — Dr. Raj Patel, R&D Head, New York Labs
"Reliable partner for high-purity vafidemstat. After-sales support is top-notch—issues resolved in hours."
★★★★★ — Mike S., Technical Director, Florida Research
Trusted by Industry Leaders: Our Social Proof
Clients: US Biotech Inc., NeuroPharm Labs, ALS Research Foundation
"Switched to Global for vafidemstat—35% cost down, zero quality issues. FDA audit passed flawlessly."
— Dr. Mark Lee, NeuroPharm Labs"High-purity vafidemstat arrived in 10 days to USA. Enabled our ALS trial acceleration by 2 months."
— Sarah Chen, US Biotech PurchasingCertifications: GMP, DMF, FDA-Compliant, ISO 9001, RoHS